Skip to main content

loratadine

Generic: LORATADINE·Brand: ALAVERT, Alavert, Alavert D, Allerclear, CHILDREN'S CLARITIN, CLARITIN, CLARITIN HIVES RELIEF, CLARITIN HIVES RELIEF REDITAB, CLARITIN REDITABS, Claritin, Claritin-D, Cleartime Indoor & Outdoor Allergies, LORATADINE, LORATADINE REDIDOSE, Loradamed, Tavist Non-Sedating, Wal-itin, Wal-itin D, Wal-vert

loratadine: 3 clinical trials tracked.

loratadine evidence translation

What we can confirm

3 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about loratadine, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

See linked entities and source evidence2 indications · 1 study sponsors
Clinical Trial Registry Records (3)

Prevent Allergic Reactions to Aphexda With Dexamethasone (PARADE)

NCT07101445Registry updated 2026-02-10·Phase 4
Recruiting

Primary endpoint: Incidence and severity of systemic reactions

InterventionalRandomizedtriple94 targetStarted 2025-09Completion 2027-121 site · United StatesEmory University

A Phase 1, Randomized, Open-label, Parallel, Single-dose Study to Assess the Pharmacokinetics, Tolerability, and Absolute Bioavailability of Subcutaneous Administration of BMS-986446, an Anti-MTBR Tau Monoclonal Antibody, in Healthy Participants

NCT06955741Registry updated 2025-10-01·Phase 1
Completed

Primary endpoint: Geometric Mean Ratio (GMR) of Maximum Observed Serum Concentration (Cmax) of BMS-986446 Administered IV versus SC

InterventionalRandomizedopen46 enrolledStarted 2025-05Completion 2025-092 sites · United StatesBristol-Myers Squibb

A Study to Investigate Safety and Tolerability of Higher Infusion Rate to shORten the duraTion of FabrazymE Infusion

NCT06019728Registry updated 2025-10-21·Phase 4·SNY
Completed

Primary endpoint: Percent Reduction in Shortest Tolerated Infusion Duration From Pre-study Average of Recent 3 Infusions

Interventionalopen8 enrolledStarted 2023-11Completion 2024-105 sites · United StatesSanofi